NCT04534309

Brief Summary

Behavioral Weight Loss for Overweight and Obese Cancer Survivors in Maryland: A Demonstration Project

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
340

participants targeted

Target at P75+ for not_applicable breast-cancer

Timeline
Completed

Started Sep 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 26, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 1, 2020

Completed
21 days until next milestone

Study Start

First participant enrolled

September 22, 2020

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2022

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2023

Completed
Last Updated

October 10, 2023

Status Verified

October 1, 2023

Enrollment Period

2.2 years

First QC Date

August 26, 2020

Last Update Submit

October 9, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Weight change at 6 months in Coach-Directed Program

    Evaluate the "effectiveness" of the Coach-Directed weight loss programs in a real world setting by examining weight change \[in kilograms (kg)\] at 6-months.

    Baseline and 6 months

Secondary Outcomes (1)

  • Weight change at 6 months in Self-Directed and App-Directed Weight Loss Programs

    Baseline and 6 months

Other Outcomes (4)

  • Program participation as assessed by participant enrollment

    End of enrollment, up to 2 years

  • Adoption of weight loss program activities as assessed by app use frequency

    6 months

  • Implementation of weight loss program as assessed by a participant survey

    6 months

  • +1 more other outcomes

Study Arms (3)

Self-Directed Weight Loss with year-long weight tracking

OTHER

Written Weight Loss Material.

Behavioral: Written Weight Loss Material

App-Directed Weight Loss with year-long weight tracking

OTHER

Smart phone Weight Loss App.

Behavioral: Weight Loss App

Coach-Directed Weight Loss with year-long weight tracking

OTHER

Behavioral Lifestyle Weight Loss Intervention with Smart phone Weight Loss App.

Behavioral: Weight Loss AppBehavioral: Behavioral Lifestyle Weight Loss Intervention (Coaching)

Interventions

Participants will receive written weight loss material by email.

Self-Directed Weight Loss with year-long weight tracking
Weight Loss AppBEHAVIORAL

Participants will receive written weight loss material as well as instructions for using a free weight loss app on their phone or computer.

App-Directed Weight Loss with year-long weight trackingCoach-Directed Weight Loss with year-long weight tracking

Participants will receive weekly coaching phone calls to encourage regular dietary, exercise, and self-monitoring practices which encourage gradual, healthy weight loss.

Coach-Directed Weight Loss with year-long weight tracking

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • previously diagnosed with a malignant solid tumor,
  • completed all required surgical, and/or chemotherapy and/or radiation curative intent therapy at least three months prior to enrollment,
  • anticipated treatment-free life span of 12 months or longer.
  • chemoprophylaxis with tamoxifen or aromatase inhibitors for breast cancer in women will be permitted
  • anti- Luteinizing-hormone releasing therapy for prostate cancer in men will be permitted.
  • BMI ≥ 25 kg/m2 (BMI ≥ 23 kg/m2 for Asians) and weight ≤ 400 lbs.
  • have an email address for regular personal use
  • Additional criteria for participants in weight tracking (self-directed or app directed)
  • willingness to record/transmit quarterly weights for 12 months
  • Additional criteria for App-Directed Program:
  • willingness to change diet and increase physical activity and track weight, diet and physical activity
  • have a smart phone for personal use
  • sufficient data plan/Internet to support daily use of weight loss app\*
  • Additional Criteria for Coach-Directed Weight Loss Program
  • willingness to lose weight by changing diet and physical activity habits
  • +7 more criteria

You may not qualify if:

  • received any chemotherapy (unless anti-hormonal therapy) and/or radiation three months or less prior to the proposed program date
  • women who are breastfeeding, pregnant, or planning pregnancy within the next year
  • self-identification of uncontrolled concurrent medical condition likely to limit compliance with the program as determined by investigators.
  • current involvement in another organized weight loss program
  • current use of steroids or other medication known to affect body weight
  • bariatric surgery scheduled within the next 6 months, or
  • plan to move outside the continental US in the next 12 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Johns Hopkins ProHealth

Baltimore, Maryland, 21207, United States

Location

Related Publications (1)

  • Jerome GJ, Appel LJ, Bunyard L, Dalcin AT, Durkin N, Charleston JB, Kanarek NF, Carducci MA, Wang NY, Yeh HC. Behavioral Weight Loss Programs for Cancer Survivors Throughout Maryland: Protocol for a Pragmatic Trial and Participant Characteristics. JMIR Res Protoc. 2024 Jun 12;13:e54126. doi: 10.2196/54126.

MeSH Terms

Conditions

Breast NeoplasmsProstatic NeoplasmsMelanomaEndometrial NeoplasmsGallbladder NeoplasmsRectal NeoplasmsKidney NeoplasmsUrinary Bladder Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesGenital Neoplasms, MaleUrogenital NeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital DiseasesNeuroendocrine TumorsNeuroectodermal TumorsNeoplasms, Germ Cell and EmbryonalNeoplasms by Histologic TypeNeoplasms, Nerve TissueNevi and MelanomasSkin NeoplasmsUterine NeoplasmsGenital Neoplasms, FemaleUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsBiliary Tract NeoplasmsDigestive System NeoplasmsBiliary Tract DiseasesDigestive System DiseasesGallbladder DiseasesColorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsGastrointestinal DiseasesIntestinal DiseasesRectal DiseasesUrologic NeoplasmsKidney DiseasesUrologic DiseasesUrinary Bladder Diseases

Study Officials

  • Jessica Yeh, Ph.D.

    Johns Hopkins University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 26, 2020

First Posted

September 1, 2020

Study Start

September 22, 2020

Primary Completion

December 15, 2022

Study Completion

June 30, 2023

Last Updated

October 10, 2023

Record last verified: 2023-10

Locations